Skip to main content

Table 1 Clinical characteristics of the two patients before surgery

From: Mammotome-assisted endoscopic breast-conserving surgery: a novel technique for early-stage breast cancer

Patient number Age/sex Tumor size (cm) TNM Hormone status HER-2 NACT regimen Tumor size (cm) after NACT
1 57/F 2.1 T2N1M0 + - Docetaxel + epirubicin 0.9
2 41/F 3.0 T2N0M0 + - Docetaxel + epirubicin 0.96
  1. NACT: Neoadjuvant chemotherapy.